Literature DB >> 15886201

BRCA1/BARD1 ubiquitinate phosphorylated RNA polymerase II.

Lea M Starita1, Andrew A Horwitz, Michael-Christopher Keogh, Chikashi Ishioka, Jeffrey D Parvin, Natsuko Chiba.   

Abstract

The breast- and ovarian-specific tumor suppressor BRCA1, when associated with BARD1, is an ubiquitin ligase. We have shown here that this heterodimer ubiquitinates a hyperphosphorylated form of Rpb1, the largest subunit of RNA polymerase II. Two major phosphorylation sites have been identified in the Rpb1 carboxyl terminal domain, serine 2 (Ser-2) or serine 5 (Ser-5) of the YSPTSPS heptapeptide repeat. Only the Ser-5 hyperphosphorylated form is ubiquitinated by BRCA1/BARD1. Overexpression of BRCA1 in cells stimulated the DNA damage-induced ubiquitination of Rpb1. Similar to the in vitro reaction, the stimulation of Rpb1 ubiquitination by BRCA1 in cells occurred only on those molecules hyperphosphorylated on Ser-5 of the heptapeptide repeat. In vitro, the carboxyl terminus of BRCA1 (amino acids 501-1863) was dispensable for the ubiquitination of hyperphosphorylated Rpb1. In cells, however, efficient Rpb1 ubiquitination required the carboxyl terminus of BRCA1, suggesting that interactions mediated by this region were essential in the complex milieu of the nucleus. These results link the BRCA1-dependent ubiquitination of the polymerase with DNA damage.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15886201     DOI: 10.1074/jbc.M414020200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  52 in total

1.  Quantitative proteomic identification of the BRCA1 ubiquitination substrates.

Authors:  Meihua Song; Kevin Hakala; Susan T Weintraub; Yuzuru Shiio
Journal:  J Proteome Res       Date:  2011-10-11       Impact factor: 4.466

Review 2.  Dysregulation of ubiquitin ligases in cancer.

Authors:  Jianfei Qi; Ze'ev A Ronai
Journal:  Drug Resist Updat       Date:  2015-09-28       Impact factor: 18.500

3.  BRCA1 ubiquitinates its phosphorylation-dependent binding partner CtIP.

Authors:  Xiaochun Yu; Shuang Fu; Maoyi Lai; Richard Baer; Junjie Chen
Journal:  Genes Dev       Date:  2006-07-01       Impact factor: 11.361

Review 4.  Functional assays for BRCA1 and BRCA2.

Authors:  Marcelo A Carvalho; Fergus J Couch; Alvaro N A Monteiro
Journal:  Int J Biochem Cell Biol       Date:  2006-08-18       Impact factor: 5.085

5.  A mechanism for transcriptional repression dependent on the BRCA1 E3 ubiquitin ligase.

Authors:  Andrew A Horwitz; El Bachir Affar; George F Heine; Yang Shi; Jeffrey D Parvin
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-09       Impact factor: 11.205

6.  Multiple mechanisms contribute to inhibit transcription in response to DNA damage.

Authors:  George F Heine; Andrew A Horwitz; Jeffrey D Parvin
Journal:  J Biol Chem       Date:  2008-02-15       Impact factor: 5.157

7.  Estrogen receptor alpha regulates expression of the breast cancer 1 associated ring domain 1 (BARD1) gene through intronic DNA sequence.

Authors:  Amy L Creekmore; Yvonne S Ziegler; Jamie L Bonéy; Ann M Nardulli
Journal:  Mol Cell Endocrinol       Date:  2007-01-16       Impact factor: 4.102

8.  Negative Regulation of AKT Activation by BRCA1.

Authors:  Tao Xiang; Amiko Ohashi; Yuping Huang; Tej K Pandita; Thomas Ludwig; Simon N Powell; Qin Yang
Journal:  Cancer Res       Date:  2008-12-15       Impact factor: 12.701

Review 9.  Nucleotide Excision Repair: Finely Tuned Molecular Orchestra of Early Pre-incision Events.

Authors:  Qianzheng Zhu; Altaf A Wani
Journal:  Photochem Photobiol       Date:  2016-11-17       Impact factor: 3.421

10.  BRCA1 targets G2/M cell cycle proteins for ubiquitination and proteasomal degradation.

Authors:  S Shabbeer; D Omer; D Berneman; O Weitzman; A Alpaugh; A Pietraszkiewicz; S Metsuyanim; A Shainskaya; M Z Papa; R I Yarden
Journal:  Oncogene       Date:  2012-12-17       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.